Restart Life Sciences (FRA:HN30) 3-Month Share Buyback Ratio : -21.44% (As of Dec. 2024 )

View and export this data going back to 2008. Start your Free Trial

What is Restart Life Sciences 3-Month Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Restart Life Sciences's current 3-Month Share Buyback Ratio was -21.44%.

Competitive Comparison of Restart Life Sciences's 3-Month Share Buyback Ratio

For the Biotechnology subindustry, Restart Life Sciences's 3-Month Share Buyback Ratio, along with its competitors' market caps and 3-Month Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Restart Life Sciences's 3-Month Share Buyback Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Restart Life Sciences's 3-Month Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Restart Life Sciences's 3-Month Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

Restart Life Sciences 3-Month Share Buyback Ratio Calculation

Restart Life Sciences's 3-Month Share Buyback Ratio for the quarter that ended in Dec. 2024 is calculated as

3-Month Share Buyback Ratio	=	(Shares Outstanding (EOP) (Sep. 2024 )	-	Shares Outstanding (EOP) (Dec. 2024 ))	/	Shares Outstanding (EOP) (Sep. 2024 )
	=	(14.832	-	18.012)	/	14.832
	=	-21.44%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Restart Life Sciences (FRA:HN30) 3-Month Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Restart Life Sciences 3-Month Share Buyback Ratio Related Terms

Restart Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Restart Life Sciences Corp (FRA:HN30) » Definitions » 3-Month Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

NMLSF:USA HN30:Germany HEAL:Canada

Address

700-838 West Hastings St, Vancouver, BC, CAN, V6C 0A6

Website

https://www.restartlife.co

Restart Life Sciences Corp is a Canadian life sciences company dedicated to addressing today's health challenges with wellness solutions. It is focus is on creating health foods that address the needs of this community. Its Flagship developments includes Autism Spectrum, Health-Related Foods, Psilocybin Clinical Trial for Fragile X Syndrome, Orphan Drug Designation (FDA and EMA).

Restart Life Sciences Headlines

No Headlines